MGTX Chart
- 52-Week Range: $8.09 - $23.74
- Market Capitalization: $389.43M
- Short Percentage: 0%
- Target Price: $30.57
- Shares Outstanding: 44.71M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
MGTX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- MeiraGTx to Participate in Upcoming Investor and Scientific ConferencesGlobeNewsWire | April 19th
- MeiraGTx Reports Fourth Quarter and Full Year 2021 Financial and Operational ResultsGlobeNewsWire | March 10th
- MeiraGTx Receives Clinical Development Milestone Payment from JanssenGlobeNewsWire | January 27th
- MeiraGTx to Host a Virtual Research and Development Day on Gene RegulationGlobeNewsWire | December 14th
- MeiraGTx Reveals Interim Data From Phase 1 Trial Of Radiation-Induced Dry Mouth SymptomBenzinga | December 7th
- MeiraGTx Reports Third Quarter 2021 Financial and Operational ResultsGlobeNewsWire | November 10th
- MeiraGTx to Present at the Chardan 5th Annual Genetic Medicines ConferenceGlobeNewsWire | September 28th
- MeiraGTx Reports Second Quarter 2021 Financial and Operational ResultsGlobeNewsWire | August 11th
Company Info
Website: https://www.meiragtx.com
Address: 430 East 29th Street, New York, NY, United States, 10016
Sector: Healthcare
Industry: Biotechnology
Full time employees: 287
Address: 430 East 29th Street, New York, NY, United States, 10016
Sector: Healthcare
Industry: Biotechnology
Full time employees: 287
$MGTX Like if you’re a bull
$MGTX I need a smoke after this trade
$MGTX ugh oh
we heatin back up
$MGTX this sell-off is meh.
$MGTX Mindset is key